ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

RPSE Res.Phm.Reg S

1.00
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Res.Phm.Reg S LSE:RPSE London Ordinary Share COM SHS USD0.0001(REG S)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Results of Annual Meeting

28/05/2009 3:48pm

UK Regulatory



 

TIDMRPSE 
 
RNS Number : 9764S 
Research Pharmaceutical SRV, Inc 
28 May 2009 
 

28 May 2009 
 
 
ReSearch Pharmaceutical Services, Inc. 
Results of Annual Meeting 
 
 
ReSearch Pharmaceutical Services, Inc. ("RPS" or the "Company"), a leading 
provider of integrated clinical development outsourcing solutions to the 
bio-pharmaceutical industry, is pleased to announce the results of its Annual 
Meeting of Stockholders held at its corporate headquarters yesterday, Wednesday 
May 27, 2009. 
 
 
The Board is pleased to announce that all resolutions relating to the common 
stock were approved by stockholders at the Annual Meeting. 
 
 
Resolution 1, electing three Class II directors to our Board, passed.  Jack 
Dean, Warren Myers and Daniel Raynor were elected to the board unanimously and 
are due for re-election at our annual meeting in 2012. 
 
 
Resolution 2 passed, ratifying the appointment of Ernst & Young, LLP as the 
independent auditors for RPS for the 2009 fiscal year. 
 
 
Full details of the resolutions were set out in the Notice of Annual Meeting, 
which was sent to stockholders on or about April 30, 2009 and are available on 
the Company's website, www.rpsweb.com.  Resolutions 1 and 2 were ordinary 
resolutions, requiring more than 50% of stockholders' votes to be cast for the 
resolutions. 
 
 
For further information please contact: 
 
 
+--------------------------------------------+----------------------------+ 
| ReSearch Pharmaceutical Services, Inc.     | +1 215 540 0700            | 
+--------------------------------------------+----------------------------+ 
| Dan Perlman, CEO                           |                            | 
+--------------------------------------------+----------------------------+ 
| Steven Bell, Chief Financial Officer       |                            | 
+--------------------------------------------+----------------------------+ 
|                                            |                            | 
+--------------------------------------------+----------------------------+ 
| Nominated Adviser and UK Broker:           |                            | 
+--------------------------------------------+----------------------------+ 
| Arbuthnot Securities Limited               |                            | 
+--------------------------------------------+----------------------------+ 
| James Steel / Ed Burbidge                  | +44 20 7012 2000           | 
+--------------------------------------------+----------------------------+ 
 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 RAGAPMITMMITBFL 
 

1 Year Res.Phm.Reg S Chart

1 Year Res.Phm.Reg S Chart

1 Month Res.Phm.Reg S Chart

1 Month Res.Phm.Reg S Chart

Your Recent History

Delayed Upgrade Clock